Cargando…
Patient-reported health outcomes for severe knee osteoarthritis after conservative treatment with an intra-articular cell-free formulation for articular cartilage regeneration combined with usual medical care vs. usual medical care alone: A randomized controlled trial
Osteoarthritis (OA) is a major public health problem characterized by joint pain, fatigue, functional limitation and decreased quality of life of the patient, which results in increased use of healthcare services and high economical costs. A promising novel bioactive cell-free formulation (BIOF2) fo...
Autores principales: | Delgado-Enciso, Ivan, Valtierra-Alvarez, Jose, Paz-Garcia, Juan, Preciado-Ramirez, Jorge, Soriano-Hernandez, Alejandro D., Mendoza-Hernandez, Martha A., Guzman-Esquivel, Jose, Cabrera-Licona, Ariana, Delgado-Enciso, Josuel, Cortes-Bazan, Jose L., Rodriguez-Sanchez, Iram P., Martinez-Fierro, Margarita L., Cabrera-Medina, Ana O., Barajas-Saucedo, Carlos E., Paz-Michel, Brenda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447772/ https://www.ncbi.nlm.nih.gov/pubmed/30988711 http://dx.doi.org/10.3892/etm.2019.7384 |
Ejemplares similares
-
A phase I–II controlled randomized trial using a promising novel cell-free formulation for articular cartilage regeneration as treatment of severe osteoarthritis of the knee
por: Delgado-Enciso, Ivan, et al.
Publicado: (2018) -
Patient-Reported Health Outcomes After Treatment of COVID-19 with Nebulized and/or Intravenous Neutral Electrolyzed Saline Combined with Usual Medical Care Versus Usual Medical care alone: A Randomized, Open-Label, Controlled Trial.
por: Delgado-Enciso, Ivan, et al.
Publicado: (2020) -
A promising novel formulation for articular cartilage regeneration: Preclinical evaluation of a treatment that produces SOX9 overexpression in human synovial fluid cells
por: Delgado-Enciso, Ivan, et al.
Publicado: (2018) -
Safety and efficacy of a COVID-19 treatment with nebulized and/or intravenous neutral electrolyzed saline combined with usual medical care vs. usual medical care alone: A randomized, open-label, controlled trial
por: Delgado-Enciso, Ivan, et al.
Publicado: (2021) -
Systemic Administration of Neutral Electrolyzed Saline as a Novel Treatment for Rheumatoid Arthritis Reduces Mechanical and Inflammatory Damage to the Joints: Preclinical Evaluation in Mice
por: Zaizar-Fregoso, Sergio A, et al.
Publicado: (2022)